Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
magazineOdyssean extends winning run of bids as Clinigen receives takeover approach
ODYSSEAN INVESTMENT TRUST (OIT) 156.5p
Gain to date: 60.5%
Original entry point: Buy at 97.5p, 10 September 2020
A takeover approach for Clinigen (CLIN:AIM) provides another boost for shareholder Odyssean Investment Trust (OIT) and extends the trust’s formidable run of selecting takeover targets.
Having attracted the attentions of activist Elliott, shares in specialist pharmaceutical products and services group Clinigen spiked on news (2 Dec) it is in talks with Triton Investment Management over a possible offer. It becomes the seventh company in Odyssean’s portfolio to receive a bid since November 2019.
Running a concentrated portfolio of smaller companies, Odyssean’s managers Stuart Widdowson and Ed Wielechowski have proven expertise in picking companies that could prove attractive to private equity or strategic trade buyers.
Results for the six months to September 2021 revealed a 13.5% rise in Odyssean’s net asset value per share, exceeding the 9.1% increase for the MSCI ex IT plus AIM Total Return index.
‘More impressively,’ explained chairman Jane Tufnell, ‘this performance has been delivered with an average net cash position in the portfolio of 22%, demonstrating the underlying strength of the performance of the portfolio companies.’
SHARES SAYS: Odyssean Investment Trust remains a buy.
Important information:
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
Issue contents
Danni Hewson
Editor's View
Feature
Great Ideas
Investment Trusts
News
- BT could go down a different path for its sports arm
- China crackdown on US listings to benefit Hong Kong Stock Exchange
- Stock markets stage full recovery after Omicron fears
- Thungela plots bumper dividend despite coal price retreat
- Stocks relevant to efforts to licence vaping for medical use
- New listing rules aim to bring more innovative companies to London
